Japan Hospice Holdings Inc. (TSE: 7061)
Health Care · Health Care Providers & Services · JP
¥463.00
-2.53% today · -64.7% 1Y
Japan Hospice Holdings Inc. (TSE: 7061) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $24.80M and employs 1,108 people.
Over the last twelve months the share price has lost 64.7%, trading between 462.00 and 1.49K.
Tweenvest scores Japan Hospice Holdings Inc. across four factors: quality 58/100, value 86/100, growth 89/100, dividend 69/100. Its strongest factor is growth.
7061 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.80M
- Revenue (TTM)
- $92.78M
- P/E
- 11.88
- EPS
- 38.97
- Dividend yield
- 5.40%
- Beta (5Y)
- 0.53
- 52-week high
- ¥1,488.00
- 52-week low
- ¥462.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.48M
- Employees
- 1,108
- Next earnings
- —
About Japan Hospice Holdings Inc.
Japan Hospice Holdings Inc. operates in Japan, focusing on two primary areas: hospice residential care and a range of home-based support services. Its hospice facilities offer specialized care for patients facing terminal cancer and intractable diseases. Beyond residential care, the company provides home-visit nursing and broader home care services. These home care offerings include medical assistance, physical care, and support for daily living, alongside multi-functional day and nursing care programs. The company was founded in 2017 and is headquartered in Tokyo, Japan.
- ISIN
- JP3750000006
- Founded
- 2017
- Listed since
- Mar 27, 2019
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Third Age Health Services LimitedNZSE: TAH | $25.52M | NZ$4.57 | -3.99% |
| Cowealth Medical Holding Co., Ltd.TPEX: 4745 | $25.27M | NT$12.20 | +2.09% |
| Aashka Hospitals LimitedBSE: 543346 | $25.24M | Rs104.45 | -1.00% |
| Microba Life Sciences LimitedASX: MAP | $24.92M | AU$0.05 | +4.08% |
| PT Royal Prima TbkIDX: PRIM | $24.73M | Rp131.00 | +6.50% |
| Lotus Eye Hospital and Institute LimitedNSEI: LOTUSEYE | $24.48M | Rs113.93 | -1.51% |
| Pharmaceutical Centre S.A.CSE: VITAF | $24.33M | €— | — |
| Cordlife Group LimitedSGX: P8A | $24.25M | S$0.12 | +7.08% |
Figures last refreshed Oct 11, 2026.